WGS
GeneDx Holdings Corp.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$66.29
+4.21%Forward multiples
Based on analyst estimates
- P/E forward
- 76.64x
- P/E 2026E
- 651.90x
- P/E 2027E
- 54.39x
- P/E 2028E
- 36.62x
- P/S forward
- 3.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.09x
- Price / sales
- 4.35x
- Price / cash flow
- -40.58x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- 4.43x
- EV / EBITDA
- -26.32x
- EV / EBIT
- -33.19x
- Market cap
- $2.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026